Value of isolated IgA anti-β2-glycoprotein i positivity in the diagnosis of the antiphospholipid syndrome

Arthritis and Rheumatism

Volumn 65, Issue 12, 2013, Pages 3186-3193

  Murthy, Vijaya ^a,b   Willis, Rohan ^a,b   Romay Penabad, Zurina ^a,b   Ruiz Limõn, Patricia ^a,b   Martínez Martínez, Laura A ^a,b   Jatwani, Shraddha ^a,b   Jajoria, Praveen ^a,b   Seif, Alan ^a,c   Alarcõn, Graciela S ^d   Papalardo, Elizabeth ^a,c   Liu, Jigna ^d   Vilá, Luis M ^e   McGwin Jr , Gerald ^d   McNearney, Terry A ^a,c   Maganti, Rashmi ^a   Sunkureddi, Prashanth ^a   Parekh, Trisha ^a   Tarantino, Michael ^f   Akhter, Ehtisham ^g   Fang, Hong ^g   Gonzalez, Emilio B ^a   Binder, Walter R ^h   Norman, Gary L ^h   Shums, Zakera ^h   Teodorescu, Marius ⁱ   Reveille, John D ^j   Petri, Michelle ^g   Pierangeli, Silvia S ^k   more..

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c ELI LILLY AND COMPANY   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^f Bleeding and Clotting Disorders Institute   (United States)

^g JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h INOVA DIAGNOSTICS INC   (United States)

ⁱ TheraTest Laboratories   (United States)

^j UNIVERSITY OF TEXAS   (United States)

^k NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; IMMUNOGLOBULIN A; THROMBOPLASTIN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN DOMAIN; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; HUMANS; IMMUNOGLOBULIN A; LONGITUDINAL STUDIES; MICE; PREVALENCE; THROMBOSIS;

EID: 84889014593     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.38131     Document Type: Article

References (30)

1. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
2. 2-glycoprotein I are the most prevalent isotypes in African American patients with systemic lupus erythematosus. Am J Med Sci 1999; 318: 55-60.
3. Pierangeli SS, Liu SW, Anderson G, Barker JH, Harris EN,. Thrombogenic properties of murine anti-cardiolipin antibodies induced by β2 glycoprotein 1 and human immunoglobulin G antiphospholipid antibodies. Circulation 1996; 94: 1746-51.
4. 2 glycoprotein-I is the most frequent isotype. Lupus 1999; 8: 263-8.
5. Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR,. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. J Rheumatol 2001; 28: 2637-43.
6. 2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus. J Rheumatol 2006; 33: 1775-9.
7. 2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome. J Rheumatol 1998; 25: 675-80.
8. 2 glycoprotein I with clinical and laboratory manifestations of systemic lupus erythematosus. J Rheumatol 2011; 38: 64-8.
9. 2-GPI. J Autoimmun 2006; 27: 266-71.
10. 2GPI? [abstract]. Lupus 2010: 19: C130.
11. 2glycoprotein I antibodies with manifestations of antiphospholipid syndrome: a case series of five patients. Lupus 2009; 18: 1011-4.
12. Sweiss NJ, Bo R, Kapadia R, Manst D, Mahmood F, Adhikari T, et al. IgA anti-β2-glycoprotein I autoantibodies are associated with an increased risk of thromboembolic events in patients with systemic lupus erythematosus. PLoS One 2010; 5: e12280.
13. 2GPI antibodies in patients with autoimmune liver diseases. J Clin Immunol 2008; 28: 501-11.
14. 2-glycoprotein I antibodies with macrovascular disease and mortality in scleroderma patients. Arthritis Rheum 2009; 60: 2480-9.
15. Reveille JD, Moulds JM, Ahn C, Friedman AW, Baethge B, Roseman J, et al, for the LUMINA Study Group. Systemic lupus erythematosus in three ethnic groups. I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. Arthritis Rheum 1998; 41: 1161-72.
16. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
17. Pierangeli SS, Harris EN,. A protocol for determination of anticardiolipin antibodies by ELISA. Nat Protoc 2008; 3: 840-8
18. 2-glycoprotein I antibodies: association with thrombosis in patients with systemic lupus erythematosus. J Rheumatol 2001; 28: 520-4.
19. 2-GPI) antibodies: importance of IgA isotype. Clin Exp Immunol 1999; 117: 574-9.
20. 2-glycoprotein I and atherosclerosis. Autoimmun Rev 2006; 6: 104-6.
21. 2-glycoprotein I antibodies as risk factors for acute myocardial infarction. Arq Bras Cardiol 2004; 83: 141-4.
22. 2- glycoprotein I and heat-shock proteins as risk factors for acute cerebral ischemia. Arq Neuropsiquiatr 2003; 61: 757-63.
23. 2-glycoprotein I in women with unexplained recurrent spontaneous abortion. Arthritis Rheum 1999; 42: 2727-8.
24. 2- glycoprotein antibodies in women who experience unexplained recurrent spontaneous abortion and unexplained fetal death. Am J Obstet Gynecol 2001; 185: 748-53.
25. Shen YM, Lee R, Frenkel E, Sarode R,. IgA antiphospholipid antibodies are an independent risk factor for thromboses. Lupus 2008; 17: 996-1003.
26. Pierangeli SS, Liu X, Espinola R, Olee T, Zhu M, Harris NE, et al. Functional analyses of patient-derived IgG monoclonal anticardiolipin antibodies using in vivo thrombosis and in vivo microcirculation models. Thromb Haemost 2000; 84: 388-95.
27. Pierangeli SS, Barker JH, Stikovac D, Ackerman D, Anderson G, Barquinero J, et al. Effect of human IgG antiphospholipid antibodies on an in vivo thrombosis model in mice. Thromb Haemost 1994; 71: 670-4.
28. Pierangeli SS, Liu X, Barker JH, Anderson G, Harris EN,. Induction of thrombosis in a mouse model by IgG, IgM and IgA immunoglobulins from patients with the antiphospholipid syndrome. Thromb Haemost 1995; 74: 1361-7.
29. Bertolaccini ML, Amengual O, Atsumi T, Binder WL, de Laat B, Forastiero R, et al. 'Non-criteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010. Lupus 2011; 2: 191-205.
30. Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012; 64: 2677-86.